These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35073813)
1. Quantification of platelet function - a comparative study of venous and arterial blood using a novel flow cytometry protocol. Törnudd M; Rodwan Al Ghraoui M; Wahlgren S; Björkman E; Berg S; Kvitting JP; Alfredsson J; Ramström S Platelets; 2022 Aug; 33(6):926-934. PubMed ID: 35073813 [TBL] [Abstract][Full Text] [Related]
2. [Role of adenosine diphosphate in the course of thrombin signal transmission]. Han Y; Lu XX; Wang ZY; Dai L; Shen WH; Wu DP; Ruan CG Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3299-301. PubMed ID: 17313817 [TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptor-induced Akt activation--regulation and possible function. Reséndiz JC; Kroll MH; Lassila R J Thromb Haemost; 2007 Dec; 5(12):2484-93. PubMed ID: 17883592 [TBL] [Abstract][Full Text] [Related]
5. Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets. Chen WF; Lee JJ; Chang CC; Lin KH; Wang SH; Sheu JR Haematologica; 2013 May; 98(5):793-801. PubMed ID: 23065519 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood. French SL; Arthur JF; Lee H; Nesbitt WS; Andrews RK; Gardiner EE; Hamilton JR J Thromb Haemost; 2016 Aug; 14(8):1642-54. PubMed ID: 26878340 [TBL] [Abstract][Full Text] [Related]
7. Identification of a Distinct Platelet Phenotype in the Elderly: ADP Hypersensitivity Coexists With Platelet PAR (Protease-Activated Receptor)-1 and PAR-4-Mediated Thrombin Resistance. Gnanenthiran SR; Pennings GJ; Reddel CJ; Campbell H; Kockx M; Hamilton JR; Chen VM; Kritharides L Arterioscler Thromb Vasc Biol; 2022 Aug; 42(8):960-972. PubMed ID: 35708029 [TBL] [Abstract][Full Text] [Related]
8. Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis. Brusilovskaya K; Simbrunner B; Lee S; Eichelberger B; Bauer D; Zinober K; Schwabl P; Mandorfer M; Panzer S; Reiberger T; Gremmel T Platelets; 2022 Aug; 33(6):879-886. PubMed ID: 35294323 [TBL] [Abstract][Full Text] [Related]
9. Platelet PAR1 receptor density--correlation to platelet activation response and changes in exposure after platelet activation. Ramström S; Oberg KV; Akerström F; Enström C; Lindahl TL Thromb Res; 2008; 121(5):681-8. PubMed ID: 17675219 [TBL] [Abstract][Full Text] [Related]
10. Platelet function in baboons and humans - A comparative study of whole blood using impedance platelet aggregometry (Multiplate®). Ponschab M; van Griensven M; Heitmeier S; Laux V; Schlimp CJ; Calatzis A; Bahrami S; Redl H; Schöchl H Thromb Res; 2016 Nov; 147():115-121. PubMed ID: 27736703 [TBL] [Abstract][Full Text] [Related]
11. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions. Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424 [TBL] [Abstract][Full Text] [Related]
12. Effects of prolactin on platelet activation and blood clotting. Wahlberg J; Tillmar L; Ekman B; Lindahl TL; Landberg E Scand J Clin Lab Invest; 2013 Apr; 73(3):221-8. PubMed ID: 23570413 [TBL] [Abstract][Full Text] [Related]
13. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation. Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652 [TBL] [Abstract][Full Text] [Related]
14. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine. Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058 [TBL] [Abstract][Full Text] [Related]
15. Protease-activating receptor-4 induces full platelet spreading on a fibrinogen matrix: involvement of ERK2 and p38 and Ca2+ mobilization. Mazharian A; Roger S; Berrou E; Adam F; Kauskot A; Nurden P; Jandrot-Perrus M; Bryckaert M J Biol Chem; 2007 Feb; 282(8):5478-87. PubMed ID: 17200114 [TBL] [Abstract][Full Text] [Related]
16. A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity. Han X; Knauss EA; Fuente M; Li W; Conlon RA; LePage DF; Jiang W; Renna SA; McKenzie SE; Nieman MT J Thromb Haemost; 2024 Jun; 22(6):1715-1726. PubMed ID: 38508397 [TBL] [Abstract][Full Text] [Related]
17. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Covic L; Gresser AL; Kuliopulos A Biochemistry; 2000 May; 39(18):5458-67. PubMed ID: 10820018 [TBL] [Abstract][Full Text] [Related]
18. Role of thrombin to non-physiological shear stress induced platelet activation and function alternation. Sun W; Han D; Awad MA; Leibowitz JL; Griffith BP; Wu ZJ Thromb Res; 2022 Nov; 219():141-149. PubMed ID: 36179652 [TBL] [Abstract][Full Text] [Related]
19. Coagulation Factor XIIIa and Activated Protein C Activate Platelets via GPVI and PAR1. De Simone I; Baaten CCFMJ; Jandrot-Perrus M; Gibbins JM; Ten Cate H; Heemskerk JWM; Jones CI; van der Meijden PEJ Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142125 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation. Wu CC; Teng CM Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]